CorMedix Inc. develops and commercializes therapeutic products aimed at treating life-threatening diseases and conditions. The company focuses on its lead product, DefenCath®, which combines taurolidine and heparin for use in medical applications. CorMedix operates primarily in the healthcare sector, targeting hospitals and healthcare providers as its main customers.
